NEOGENOMICS INC — Director's Dealing 2014

Apr 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-03-28

Reporting Person: ALBITAR MAHER (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-28	Common Stock	P	14492	$3.5086	Acquired	48492	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy)	$1.43	2017-01-09	Common Stock (250000)	250000	Direct
Warrants (Right to Buy)	$1.43	2017-01-09	Common Stock (200000)	200000	Direct

Footnotes

F1: These stock options were granted upon the start of Mr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.

F2: These warrants were issued to Mr. Albitar upon the start of his service to the Company and vest upon the acheivement of certain currently unmet milestones.